Siegel R, Miller K, Jemal A (2017) Cancer statistics. CA Cancer J Clin 67:7–30
Article
Google Scholar
Dupuy D, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, Mayo-Smith W (2006) Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 129:738–745
Article
Google Scholar
Mylonaki E, Manika K, Zarogoulidis P, Domvri K, Voutsas V, Zarogoulidis K, Mourelatos D (2012) In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy. Mut Res Fundamental Mol Mechanisms Mutagen 740:1–5
Article
CAS
Google Scholar
Kar U, Srivastava M, Andersson A, Baratelli F, Huang M, Rome LH, Sharma S (2011) Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth. PLoS One 6:e18758
Article
CAS
Google Scholar
Li G, Mivechi N, Weitzel G (1995) Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. Int J Hyperth 11:459–488
Article
CAS
Google Scholar
Isık A, Sanlı M, Yılmaz M, Meteroglu F, Dikensoy O, Sevinc A, Camcı C, Tuncozgur B, Elbeyli L (2013) Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies. Respir Med 107:762–767
Article
Google Scholar
Rossi S, Dore R, Cascina A, Vespro V, Garbagnati F, Rosa L, Ravetta V, Azzaretti A, Di Tolla P, Orlandoni G, Pozzi E (2006) Percutaneous computed tomographyguided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 27:556–563
Article
CAS
Google Scholar
Gridelli C, Ardizzoni A, Chevalier T, Manegold C, Perrone F, Thatcher N, Zandwijk N, Di-Maio M, Martelli O, De-Marinis F (2004) Treatment of advanced non small-cell lung cancer patients with ECOG performance status 2: results of a European Experts Panel. Ann Oncol 15:419–426
Article
CAS
Google Scholar
Fernando HC, De Hoyos A, Landreneau RJ, Gilbert S, Gooding WE, Buenaventura PO, Christie NA, Belani C, Luketich JD (2005) Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 129:639–644
Article
Google Scholar
Goldstraw P, Crowley J, Chansky K, Giroux D, Groome P, Rami-Porta R, Postmus P, Rusch V, Sobin L (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming 7 th edition of the TNM Classification of malignant tumors. J Thorac Oncol 2:706–714
Article
Google Scholar
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt W, Nicholson A, Groome P, Mitchell A, Bolejack V, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions (2016) The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 11:39–51
Article
Google Scholar
Monga S, Wadleigh R, Sharma A, Adib H, Strader D, Singh G, Harmon J, Berlin M, Monga D, Mishra L (2000) Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer. Am J Clin Oncol 23:386–392
Article
CAS
Google Scholar
Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, Vog T, Goldberg EP, Huang H, Simoff M, Li Q, Browning R, Turner FJ, Pivert PL, Spyratos D, Zarogoulidis K, Celikoglu SI, Celikoglu F, Brachmann J (2013) Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies. Drug Design Dev Ther 7:571–583
CAS
Google Scholar
Scagliotti G, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26:3543–3551
Article
CAS
Google Scholar
Celikoglu F, Celikoglu S, York A, Goldberg E (2006) Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer. Lung Cancer 51:225–236
Article
Google Scholar
Zhao Z, Zhao S, Ren M, Liu Z, Li Z, Yang L (2017) Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis. Oncotarget 8:100640–100647
Article
Google Scholar
El-Badrawy M, El-Shafey M, Hewidy A, Tohlob M, Akl F, Ebrahim M (2017) Hot saline thermoablation of peripheral non small cell lung cancer safety and efficacy: a pilot study. Int J Resp Dis Care Med 2:14–21
Google Scholar
He J, Ying W, Yang H, Xu X, Shao W, Guan Y, Jiang M, Wu Y, Zhong B, Wang D, Tucker S, Zhong N (2009) Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension. Anti-Cancer Drugs 20:838–844
Article
CAS
Google Scholar
Li X, Zhao M, Wang J, Fan W, Li W, Pan T, Wu P (2013) Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. AJR 201:1362–1367
Article
Google Scholar
Sun Y, Song P, Guo Y, Sheng L (2015) Computed tomography-guided percutaneous microwave ablation therapy for lung cancer. Genet Mol Res 14:4858–4864
Article
CAS
Google Scholar
Gaafar R, Hamza R, Khaled H, El-Serafi M, Mansour O, Karim N, Abdelmoneim D, El-Attar I, Soliman S (2004) Gemcitabine and cisplatin in the treatment of advanced non – small cell lung cancer: National Cancer Institute Cairo experience. J Egyptian Nat Cancer Inst 16:1–7
Google Scholar
Ambrogi M, Fanucchi O, Cioni R, Dini P, De Liperi A, Cappelli C, Davini F, Bartolozzi C, Mussi A (2011) Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol 6:2044–2051
Article
Google Scholar
Kodama H, Yamakado K, Takaki H, Kashima M, Uraki J, Nakat-suka A, Takao M, Taguchi O, Yamada T, Takeda K (2012) Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention. Cardiovasc Intervent Radiol 35:563–569
Article
Google Scholar